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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To assess the effects of DMT on behavioural, social, cognitive and emotional problems of people with dementia in comparison
to no treatment (waiting list), standard care or any other treatment.
2. To compare different forms of DMT (e.g. Laban-based DMT, Chacian DMT or Authentic Movement).
B A C K G R O U N D
Description of the condition
Dementia is a collective name for a number of different progres-
sive degenerative brain syndromes that have effects on memory,
thinking, behaviour, emotions and social functioning.
People living with dementia may have symptoms such as:
• memory loss;
• not being able to find the right words or understand what
people are saying;
• having difficulties in performing what used to be routine
tasks;
• mood swings and personality changes.
These symptoms limit their ability to communicate with others,
may reduce social engagement and, in turn, can lead to apathy, or
aggressiveness (Chen 2000), or depression (Lyketsos 2004). Facing
cognitive, emotional and social challenges may increase the risk of
challenging behaviours related to dementia (Shaji 2009).
According to Alzheimer’s Disease International (ADI 2010),
Alzheimers disease is the most common of these syndromes and
is followed by vascular dementia, Lewy body dementia and fron-
totemporal dementia. The same source argues that the different
types of dementia affect approximately 35.6million people world-
wide. Furthermore, it is estimated that, as a result of the popu-
lation growing older, by 2030 there will be 65.7 million people
suffering from dementia worldwide, and by 2050 there will be
115.4 million. Although recent studies suggest that populations
that were born later in the 20th century have a lower risk of devel-
oping dementia than those born earlier (Matthews 2013), demen-
tia remains a major issue for aging populations with immediate
and major impact upon families, services and societies as a whole.
Historically, treatment interventions focused on reducing cogni-
tive deterioration through pharmacological interventions. How-
ever, current thinking highlights the value of treatment options
that address the person as a whole, including their physical, emo-
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tional, social and cognitive processes (Kitwood 1997). Further-
more, there is a growing literature that argues for the value of the
arts and embodied practices for this population, as being capable
of bypassing impairments, connecting with people at a pre-cogni-
tive level, reducing the risk of dementia and slowing down the pro-
gressive nature of the disease (Sandel 1987; Palo-Bengtsson 2002;
Verghese 2003; Burns 2008; Hayes 2011; Vink 2011). Dance
movement therapy (DMT) is one of these interventions that may
be a useful intervention for people suffering with dementia.
Description of the intervention
DMT is a form of psychotherapy, one of the arts therapies and
a treatment option for people with dementia as reported by
Hill 1999, Coaten 2001, Coaten 2002, Violets-Gibson 2002,
Kowarzik 2004, Hill 2006 and Hayes 2011.
DMT is also known as dance therapy, movement therapy, dance
movement psychotherapy, movement psychotherapy, dance/
movement therapy or dance-movement therapy. One of the offi-
cial definitions available for the discipline describes it in the fol-
lowing terms:
“Dance Movement (Psycho) therapy is the psychotherapeutic use
of movement and dance through which a person can engage cre-
atively in a process to further their emotional, cognitive, phys-
ical and social integration. It is founded on the principle that
movement reflects an individual’s patterns of thinking and feeling.
Through acknowledging and supporting clients’ movements, the
therapist encourages development and integration of new adap-
tive movement patterns together with the emotional experiences
that accompany such changes” (Association for Dance Movement
Psychotherapy UK ADMP UK 2012, p 1).
DMT is regarded as a useful and appropriate intervention for pa-
tients with a range of conditions, diagnosis and presenting prob-
lems, and especially those for whom words can be difficult, those
with a cognitive impairment, or who just find it difficult to express
and explore their emotions through words. This type of therapy
can take place in a number of different settings including health
services, schools, social services, voluntary organisations and pris-
ons. Sessions can last from 30 to 90 minutes and often take place
weekly at an agreed place and time. Interventions may last from a
few weeks to several months, depending on client needs, and can
be delivered as one-to-one, pair- or group-therapy.
The practice of DMT in the 21st century stems in part from
pioneering work that took place in theUSA during themiddle and
latter part of the last century. For example,MarianChace (Chaiklin
1986; Levy 1992), an American dancer, developedDMTmethods
that are still widely used today. These methods include the use
of the circle and active mirroring in DMT sessions; both of these
methods encourage the development of non-verbal therapeutic
relationships. However, pioneers in other countries also developed
approaches that initially were independent of American influences
(Payne 1992; Meekums 2008).
Karkou 2006 identifies three main models in the field, namely:
1. approaches that rely primarily upon dance/movement
engagement and aim to explore specific movement themes and
qualities. Examples of these are often, though not exclusively,
informed by Rudolf Laban, an early proponent of therapeutic
applications of dance movement (Laban 1975);
2. approaches that prioritise the non-verbal interaction
between client(s) and therapist. A good example of this is the
interactive model developed by the American DMT pioneer
Marion Chace, as described by Chaiklin 1986, in which
mirroring is a key technique, i.e. an active reflection of the
movement qualities of the client by the therapist (and at times
other group members);
3. approaches that focus on movement improvisation
associated with internal work, in the presence of the therapists.
An example of this type of approach comes from Authentic
Movement, a way of working developed by the American
choreographer Mary Whitehouse in which the therapist stays
still and observes, using the self as an empathic witness
(Whitehouse 1979).
In these approaches to DMT, the therapist may be active (mov-
ing with participants, as in the Chacian approach), or adopt a
more observational stance (as in AuthenticMovement). Meekums
2008 suggests that the feature that marks out contemporary DMT
practice is the emphasis on it as a form of psychotherapy. For
many therapists, theories relating to psychoanalytic and psycho-
dynamic principles are used to guide practice (Karkou 2006). For
example, AuthenticMovement is associated with Jungian psychol-
ogy (Whitehouse 1979), while the interactive model of Marion
Chace is closely connected with humanistic thinking. For others,
developmental, behavioural or eclectic and integrative models are
valued (Karkou 2006). For example, in her work with mothers
and young children Meekums used a behavioural approach com-
bined with attachment theory (Meekums 1991). More recently,
Meekums suggested an integrative framework based on the sym-
bolic power of the ’movement metaphor’, which transcends such
theoretical divisions (Meekums 2002).
In all cases, the therapist is concerned with developing an embod-
ied empathic relationship. Within this relationship, the therapist’s
body may be seen as holding projections from individual clients,
or from the group as a whole. These projections can be worked
through verbally, or non-verbally, or both; more or less verbal re-
flection may take place, depending on the level of cognitive func-
tioning of the participants.
How the intervention might work
DMT may have positive effects for people with dementias that
include delaying cognitive deterioration, improving mood and in-
creasing social interaction for a number of reasons such as: 1) the
use of movement as exercise and as dance, 2) the use of music, 3)
the therapeutic relationship, and 4) DMT-specific features.
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The use of movement
Since DMT uses the body and encourages movement amongst
participants, it is expected that there will be some physiological
changes associated with exercise. These are well documented in
the generic literature on the physiology of exercise, and include
positive effects on cognitive function (Colcombe 2003).
The dance literature related to this review reveals that some dance
forms, such as tango, may have the effect of over-riding problems
in the brain associated with balance and gait in Parkinson’s Disease
(Hackney 2007; Hackney 2010). Tango has many of the elements
also found in a DMT session, including: ’ . . . frequent movement
initiation and cessation, a range of speeds, rhythmic variation . . .
’ (Hackney 2010; p 682).
The use of music
Although not essential, it is common for dance movement ther-
apists to use music when working with people with dementias.
Studies included in the Cochrane Review by Vink 2011 indicate
that music therapy, a discipline closely alligned to DMT, may have
some moderate positive effects in reducing behavioural symptoms
associated with dementia, stimulating language skills and enhanc-
ing social/emotional functioning. However, in a similar way to
other systematic reviews that have evaluated emerging treatment
options, the authors of the review concluded that themethodolog-
ical rigour and reporting of findings of these studies was too poor
to draw useful conclusions about the value of this intervention.
The therapeutic relationship
As a form of psychotherapy, the therapeutic relationship can be
seen as a key agent for change (Norcross 2011; Macaskie 2012).
For example, in verbal psychotherapy - and with regard to inter-
subjective therapeutic relationships in particular - Macaskie 2012
concludes that the relationship is an embodied one, drawing on
implicit relational knowing, implicit body memory and embodied
participatory sense-making. Within DMT, embodied relational
knowing, body memory and embodied sense-making are highly
developed. Furthermore, empathy - a core component of the ther-
apeutic relationship - is extensively utilised in DMT in the form
of a sophisticated understanding and use of kinaesthetic empathy
(Meekums 2012a). The development of a therapeutic relationship
is a key aspect of the work and one of themain differences between
DMT and dance practice.
DMT-specific features
While DMT participants do engage in movement initiation and
cessation, rhythmic variation and a range of speeds, they are en-
couraged to engage in movement that is primarily creative rather
than learning steps to music. Additional benefits, therefore, might
reasonably be expected beyond those associated with exercise or
dance classes.
Karkou 2006 argues that therapeutic change may be related to
some of the unique features of DMT specifically: embodiment,
creativity and improvisation, movement-based imagination, the
use of symbolicmovement and the use ofmovement as ametaphor.
The embodied nature of DMT makes it potentially relevant to
those clients for whom body image or body memory may be a par-
ticular issue requiring exploration and working through, for exam-
ple for people who are overweight and have emotional eating pat-
terns (Vaverniece 2012). In the case of dementia, engaging body
memories may assist the goals of reminiscence therapy (Woods
2009). Metaphors inherent in symbolic movement offer a way to
understand communication (Meekums 2002), andmay be impor-
tant for communication by people with dementia (Young 2011).
Creativity and improvised movement work enable participants to
develop new ways of being in the world in themselves and in inter-
actions with others, and to delay cognitive deterioration (Karkou
2006). The value of activating imagination through movement
has been extensively discussed by Dosamanstes-Alperson as early
as 1981 (Dosamantes-Alperson 1981). Furthermore, Meekums
2002 and Karkou 2006 argue that symbols and metaphors can
increase emotional distance from distressing memories and feel-
ings, while they can allow for safe explorations that may change
cognitions and feelings.
One of the central aspects of DMT for which there is an evidence
base relates to the use of non-verbal communication, and kinaes-
thetic empathy in particular (Brooks 1989; Berrol 2006;Meekums
2012a), which is an important aspect of the therapeutic relation-
ship discussed above. ’Movement mirroring’ is a technique exten-
sively used by dance movement therapists as a way of engaging pa-
tients and achieving non-verbal empathy. Within DMT literature
empathic engagement through mirroring is often seen as linked
with the activation of mirror neurones in the brain (Rizzolatti
1996;Meekums 2002; Berrol 2006; Gazzola 2006), which fire as a
kind of body memory when an individual observes another person
engaged in either purposeful movement or emotional expression
that is within the repertoire of the observer. However, the signifi-
cance of mirror neurones within therapeutic kinaesthetic empathy
is unclear; emotional engagement through a deliberate attempt to
imagine oneself into another’s experience appears to be an impor-
tant additional requirement (Meekums 2012a). Moreover, mirror
neurone activity is associated with watching movements; different
processes may be involved in actively mirroring movements, and
so while some aspects of kinaesthetic empathy may involve mirror
neurone activity, the processes involved in conveying empathy are
likely to be different.
Further investigation is needed on this topic as well as on clarifying
whether both specific and non-specific factors may be responsible
for any therapeutic change associated with DMT for clients with
dementia.
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Why it is important to do this review
DMT is widely practised around the world in both statutory and
non-statutory sectors. In Britain for example, the profession is reg-
ulated by the Association forDanceMovement PsychotherapyUK
(ADMP UK). In Europe, the Association for Dance Movement
Therapy was founded recently, while in the USA dance/move-
ment therapists receive national Certification from the Dance/
Movement Therapy Certification Board, an independent affiliate
of theAmericanDanceTherapyAssociation. Evidence is currently
growing that this intervention is effective with a range of client
groups. The current review will add to other completed Cochrane
reviews of studies in DMT that have reviewed research evidence
on the effects of DMT on schizophrenia, cancer care and depres-
sion (Bradt 2011; Meekums 2012b; Ren 2013).
Furthermore, there is a growing need to offer appropriate services
to people with dementias who are faced with multiple issues be-
yond traditional pharmacological treatment. Given that medica-
tion focuses primarily on reducing cognitive deterioration, and
that there is a growing number of dementias with multiple symp-
toms and difficulties, the search for effective interventions that
claim to address the person as a whole is becoming particularly
urgent. DMT claims to treat the person as a whole, tapping not
only into cognitive areas of functioning but also emotional, social
and physical aspects. The current review, therefore, will add to the
literature of non-pharmacological treatment options for demen-
tia.
O B J E C T I V E S
1. To assess the effects of DMT on behavioural, social,
cognitive and emotional problems of people with dementia in
comparison to no treatment (waiting list), standard care or any
other treatment.
2. To compare different forms of DMT (e.g. Laban-based
DMT, Chacian DMT or Authentic Movement).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Our review will include published or unpublished randomised
controlled trials (RCTs) in any language. We will also consider
cross-over designs and cluster-RCTs.
Types of participants
The review will include studies of people who, according to the
DSM-IV, ICD-10 or other comparable diagnostic criteria, have
been formally diagnosed as having any type of dementia of any
type of severity. Women and men in all age groups and in all
settings (e.g. statutory and voluntary organisations, in-patient or
out-patient) will be considered for inclusion in the review.
We will identify the inclusion criteria that determined the selec-
tion of participants for each trial. When this information is not
available in the source material, we will contact the trial authors to
determine how they screened participants, and how many people
declined to participate.
Types of interventions
Experimental interventions
We will consider interventions delivered by a DMT practitioner
who: has received formal training; is a dancemovement therapist in
training; or is otherwise recognised as a dance movement therapist
in the country in which the study was conducted.
We will include both group, individual and family/couple DMT
with any number and duration of sessions.
Sessions must include active involvement in dance/movement in
the presence of a dance movement therapist, or dance/movement
interactionwith a dancemovement therapistwith orwithout other
group members, or both. Dance/movement can be improvisatory
or structured. Sessions will have clear therapeutic intent and a
clear description of the intervention will be reported or available
on request. All approaches to DMT will be considered.
The presence or absence of verbal interaction and reflection will be
considered as a factor to be examined in subgroup analysis. In all
cases however, creative movement work may be the main means of
working through cognitive, behavioural, emotional or social issues
faced by the participants.
Comparators
1. No treatment or standard care.
2. Psychological therapies: e.g. counselling, verbal
psychotherapies including psychodynamic psychotherapy,
interpersonal therapy or cognitive behavioural therapy.
3. Pharmacological interventions: medications such as
cholinesterase inhibitors (CgEIs) or memantine.
4. Other interventions: e.g. exercise, dance or music.
5. Different types of DMT: different types of DMT, as defined
above.
Types of outcome measures
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Primary outcomes
Changes in challengingbehaviours (e.g. wandering, agitation, gen-
eral restlessness), cognitive functioning, levels of depression and
quality of life; examples of tools for assessing each outcome are
listed below.Wewill accept all behavioural and psychological tools
reported by the authors of the identified primary studies in the
same way that Vink did for the Vink 2011 review of music therapy
for dementia.
1. Challenging behaviours:
i) quantitative observational tools specifically designed
for an individual study to measure frequency of occurrence of
wandering, agitation and general restlessness;
ii) standardised tests such as: Cohen-Mansfield Agitation
Inventory Clifton (CMAI; Cohen-Mansfield 1989) scoring from
29 to 203; the higher the total score the more frequent the
agitated behaviours.
2. Cognitive functioning:
i) the Mini-Mental State Exam (MMSE) (Folstein
1975); scoring from 0 to 30 with lower scores indicating poorer
cognitive function;
ii) Alzheimers Disease Assessment Scale (ADAS-cog;
Rosen 1984); scores on the cognitive subscale range from 0 to 70
with higher scores indicating poorer cognitive function.
3. Depression:
i) Cornell Scale for Depression in Dementia
(Alexopoulos 1988); scoring from 0 to 38 with higher scores
indicating more severe depression.
4. Quality of life:
i) Quality of Life-Alzheimer’s Disease (QOL-AD,
Logsdson 1999): scoring from 13 to 52; higher scores suggest
better quality of life.
If other similar outcome measures are found in the included stud-
ies, they will be considered.
Secondary outcomes
Mobility and balance, fatigue, anxiety, social and occupational
functioning, economic outcomes (cost-effectiveness of treatment),
treatment or research discontinuation/dropout (as measures of ac-
ceptability). Adverse events will also be considered, including falls
and injuries associated with the intervention. Outcomes will be
included as used within the primary studies.
Search methods for identification of studies
Electronic searches
We will search ALOIS (www.medicine.ox.ac.uk/alois) - the
CochraneDementia andCognitive ImprovementGroup’s Special-
ized Register. The search terms used will be: “dance*” or “authen-
tic movement” or “movement therap*” or “movement psychot*”
or “body psychot*”.
ALOIS is maintained by the Trials Search Co-ordinator of the
Cochrane Dementia Group and contains dementia and cognitive
improvement studies identified from:
1. monthly searches of a number of major healthcare
databases: MEDLINE, EMBASE, CINAHL, PsycINFO and
LILACS;
2. monthly searches of a number of trial registers: meta
Register of Controlled Trials; Umin Japan Trial Register; WHO
portal (which covers ClinicalTrials.gov; ISRCTN; Chinese
Clinical trials Register; German Clinical trials register; Iranian
Registry of Clinical trials and the Netherlands National Trials
Register, plus others);
3. quarterly search of The Cochrane Library’s Central register of
Controlled trials (CENTRAL);
4. monthly searches of a number of grey literature sources: ISI
Web of knowledge Conference Proceedings; Index to Theses;
Australasian Digital Theses.
To view a list of all sources searched for ALOIS see About ALOIS
on the ALOIS website.
Additional separate searches will be run in many of the above
sources to ensure that the most up-to-date results are retrieved.
The search strategy that will be used for the retrieval of reports of
trials from MEDLINE (via the Ovid SP platform) can be seen in
Appendix 1.
Searching other resources
We will also do the following in order to identify published, un-
published and on-going trials that may not appear in the electronic
searches listed above.
1. We will search the bibliographies of relevant studies and
reviews.
2. We will contact professional associations and educational
programmes in DMT from around the world using a standard
request form to inform us of Masters-degree, PhD or
independent work that is published or unpublished, completed
or ongoing that might meet the inclusion criteria.
3. We will contact DMT researchers, theoreticians and
practitioners who specialise in this area of work, whom we will
regard as experts in the field.
Data collection and analysis
Selection of studies
In the first instance, the two authors (VK and BM) will screen
titles and abstracts for inclusion of studies that meet the inclusion
criteria as discussed in Criteria for considering studies for this
review and further specified in Data extraction and management.
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The two review authors will act independently and will assess
different studies’ eligibility using the first part of the proforma that
can be found in Appendix 1.
All potentially relevant titles and abstracts will be recorded and
assessed to decide whether they should be included, excluded or
whether additional information is required regarding:
1. general information
2. inclusion criteria
i) study design
ii) participants
iii) interventions
iv) outcomes
A final decision will be made only after additional information
has been sought, where required. If there are disagreements, the
two authors will meet to discuss them and, if required, will seek
a third opinion from the Cochrane Dementia and Cognitive Im-
provement Group. A record will be kept of all studies, charting the
decisions made, and the stage at which these decisions were made
(i.e. title and abstract, on further inquiry from the authors, or on
reading the full paper), together with the reason for this decision.
Data extraction and management
Full reports will be obtained of all included studies. A proforma
specifically designed for this purposewill be used to extract relevant
data from all included studies (see Appendix 2). The two review
authors will extract data independently using this data extraction
proforma. Again, any disagreements will be resolved by discussion;
where this does not result in agreement, a third opinion will be
sought from theCochrane Dementia and Cognitive Improvement
Group.
The following details will be extracted (as presented in Appendix
2):
1. study characteristics;
2. interventions;
3. outcome measures used in the study;
4. study results;
5. additional notes.
Assessment of risk of bias in included studies
In order to identify any risk of bias in the included studies, we will
use the Cochrane Risk of Bias tool as presented in Appendix 2 (
Higgins 2011).With the aid of this tool, wewill make a judgement
of ’low risk’, ’high risk’ or ’unclear risk’ of bias for each trial of the
following areas:
1. selection bias:
i) random sequence generation
ii) allocation concealment
2. blinding of participants and personnel;
3. blinding of outcome assessment;
4. incomplete outcome data;
5. selective reporting;
6. other sources of bias.
Measures of treatment effect
When changes in challenging behaviours (e.g. wandering, agita-
tion, general restlessness), cognitive functioning, depression and
quality of life are measured using rating scales presented as di-
chotomous data, we will summarise data using risk ratios (RR).
For continuous outcomes, such as scores from a scale, we will use
mean differences (MD).
When different scales are used to measure the same outcome, the
standardisedmeandifferencewill be calculated inReviewManager
(RevMan 2012) to summarise outcomes across scales.
In all cases endpoint data will be regarded as a superior method
over change scores. This is preferred since data can be skewed in
favour of the treatment or the control group where randomisation
is inadequate. It is possible that change scores could appear as
different when in fact the two end points (control and treatment
group) are similar (see, for example, Meekums 2012b).
Unit of analysis issues
We are not expecting to find large scale studies taking place in this
area, but depending on the type of studies available we will make
the following choices:
1. in the case of cross-over trials, we will use only the first
active treatment period;
2. in studies with multiple arms we will include only the arm
with DMT and the control;
3. in the case of two DMT arms with one single control
group, we will consult the Cochrane Handbook (Higgins 2011,
chapter 16.5.4).
If there is a cluster randomisation, depending on the data avail-
able, analysis will follow the Cochrane Handbook (Higgins 2011,
chapters 16.3.3 to 16.3.7).
Dealing with missing data
If there aremissing data in terms of end of treatment scores, wewill
attempt either to obtain the missing data or find out why data are
missing through contacting trialists. Data that remain unavailable
will be treated as ’missing at random’ (Higgins 2011, 16.1.2), and,
if it is end of treatment scores that are missing we will assume that
participants either dropped out of the intervention, died or became
too ill to continue. The percentage drop-out will be calculated,
and cautiously interpreted as a measure of acceptability.
If standard deviations (SD) are missing, we will consider the values
of other reported measures such as P values, t values, confidence
intervals and standard errors. If a sufficient number of studies
become available, we will try to impute a SD. We will however,
make a note of this, and we will perform a sensitivity analysis, as
imputed measures may bias towards lack of effect.
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For continuous data that remain missing, we plan to report com-
pleters’ data only. For binary data, we will assume that drop-outs
had ’no change’ and we will analyse using intention to treat anal-
ysis.
In general terms, we will report all missing data in the risk of bias
tables (Appendix 2).
Assessment of heterogeneity
Initially, sources of clinical heterogeneity will be examined; stud-
ies will be pooled only where review authors judge that there is
sufficient clinical homogeneity. In order to assist our judgement
regarding potential sources of clinical heterogeneity, we will sum-
marise studies in terms of participants, settings,method of delivery
(that is, group or individual, number of sessions), type of DMT,
and reported outcomes.
We will assess heterogeneity in the results of the trials by inspec-
tion of graphical presentations and by the I2 and Chi2 statistics
(Higgins 2011).
We will pool studies with I2 values of up to 80% heterogeneity,
whichmay be an acceptable level of heterogeneity for psychological
assessments.Wewill then perform a sensitivity analysis to establish
the effects of including studies of lower quality (see Sensitivity
analysis).
Assessment of reporting biases
Where there are more than ten studies that address the same out-
come, we will use a funnel plot analysis to examine for publication
bias.
Data synthesis
Data from all trials included in the review will be entered into Re-
view Manager software (RevMan 2012). Depending on the out-
come of the test for homogeneity, we will be able to assess whether
we need to accommodate for heterogeneity by using a random-
effects model to calculate differences between treatment and con-
trol groups and pooled estimates.
A meta-analysis will be performed on extracted data, if:
1. there is more than one study with an estimated treatment
effect;
2. the included studies appear to differ minimally in
characteristics and can be investigated for heterogeneity through
subgroup analyses;
3. studies use the same outcome measures;
4. each study has available data (Higgins 2011; Meekums
2012b).
Finally, as it is expected that studies will use different time points
for measurement, an initial main analysis will be based on the
final time point. Following this, sub-group analysis will also be
considered as follows: short follow-up (up to 14 weeks); moderate
follow-up (15 to 27 weeks) and long follow-up (28 weeks and
over). In cases where the type of intervention, the populations
studied or the outcome measures used are very different from one
study to another, only narrative descriptions of the findings will
be included in the review.
Subgroup analysis and investigation of heterogeneity
If possible, we will perform subgroup analyses as follows:
1. mode of delivery including group or individual;
2. actively moving or not actively moving therapist;
3. presence or absence of verbal interaction;
4. length of treatment including number of sessions (fewer
than 12 sessions versus 12 or more sessions);
5. intensity of intervention, to include frequency (weekly or
less frequent, bi-weekly or more frequent) and duration of
sessions (one hour or less, more than one hour);
6. type of dementia;
7. severity of dementia (mild, moderate or severe as defined by
the trialist);
8. participant characteristics including gender (men, women
or other) and age (under 65 years old; 65 years old and over);
9. setting (statutory and non-statutory).
Sensitivity analysis
If it is relevant, the following types of sensitivity analysis will be
performed relating to:
1. different types of risk of bias, for example high versus low
risk studies;
2. imputed measures vs available case analysis.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. danc*.ti,ab.
2. DTM.ti,ab.
3. “authentic movement*”.ti,ab.
4. “movement therap*”.ti,ab.
5. “movement psychot*”.ti,ab.
6. “body psychot*”.ti,ab.
7. “body psychot*”.ti,ab.
8. or/1-7
9. Dance Therapy/
10. 8 or 9
11. exp Dementia/
12. Delirium/
13. Wernicke Encephalopathy/
14. Delirium, Dementia, Amnestic, Cognitive Disorders/
15. dement*.mp.
16. alzheimer*.mp.
17. (lewy* adj2 bod*).mp.
18. deliri*.mp.
19. (chronic adj2 cerebrovascular).mp.
20. (“organic brain disease” or “organic brain syndrome”).mp.
21. (“normal pressure hydrocephalus” and “shunt*”).mp.
22. “benign senescent forgetfulness”.mp.
23. (cerebr* adj2 deteriorat*).mp.
24. (cerebral* adj2 insufficient*).mp.
25. (pick* adj2 disease).mp.
26. (creutzfeldt or jcd or cjd).mp.
27. huntington*.mp.
28. binswanger*.mp.
29. korsako*.mp.
30. or/11-29
31. 10 and 30
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Appendix 2. Sample of data extraction form
Information/data extracted for all relevant studies
General information
• ’Data extractor’/author ID
• Date of extraction
• Study ID
• Title, author/s, publication details of study
• Source if unpublished
• Language of publication
Eligibility criteria
Does the study meet the inclusion criteria, and how?
• Study design (parallel, controlled trial, randomised controlled trial, systematic allocation)
• Participants (diagnosis of dementia)
• Interventions (type of dance movement therapy)
• Outcomes (changes in cognitive, behavioural, emotional or social scales)
Inclusion? Exclusion? More information needed?
Data extraction for included studies
Study characteristics
• Study setting (e.g. country, urban/rural, hospital/clinic/school/charity/community/prison etc
• Participant demographics (e.g. age, gender, socio-economic status, co-morbidity)
• Inclusion/exclusion criteria used in the study
Outcome measures used in the study
• Primary outcome measures that provide scores for changes in:
◦ Challenging behaviours
◦ Cognitive functioning
◦ Depression
◦ Quality of life
• Secondary outcome measures that provide scores for:
◦ mobility and balance
◦ Fatigue
◦ Anxiety
◦ Social and occupational functioning
◦ Economic outcomes
◦ Treatment or research discontinuation/dropout
◦ Adverse events including falls and injuries associated with the intervention
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Study results
• Source (table, graph, text)
• Participants, number of events, percentages, chi-squares, risk ratios, for dichotomous outcomes, mean differences or
standardised mean differences for continuous outcomes, missing participants
• Queries regarding data or methods (to be referred to the author for further information)
Additional notes
• Record of details regarding correspondence with author/s for additional information or clarification of queries
• Ethics of stated conflict of interest
• Details of other studies cited in the references
• Duplicate publications
• Translation required
Risk of bias assessment tool (Higgins 2011)
Domain Support for judgement Review authors’ judgement
Selection bias
Random sequence generation Describe the method used to generate the
allocation sequence in sufficient detail to
allow an assessment of whether it should
produce comparable groups
Selection bias (biased allocation to inter-
ventions) due to inadequate generation of
a randomised sequence
Allocation concealment Describe the method used to conceal the
allocation sequence in sufficient detail to
determinewhether intervention allocations
could have been foreseen in advance of, or
during, enrolment
Selection bias (biased allocation to inter-
ventions) due to inadequate concealment
of allocations prior to assignment
Performance bias
Blinding of participants and personnel:
assessments should be made for each main
outcome (or class of outcomes)
Describe all measures used, if any, to blind
study participants and personnel from
knowledge of which intervention a partici-
pant received. Provide any information re-
lating towhether the intendedblindingwas
effective
Performance bias due to knowledge of the
allocated interventions by participants and
personnel during the study
Detection bias
Blinding of outcome assessment: assess-
ments should be made for each main out-
come (or class of outcomes)
Describe all measures used, if any, to
blind outcome assessors from knowledge
of which intervention a participant re-
ceived. Provide any information relating to
whether the intended blinding was effec-
tive
Detection bias due to knowledge of the al-
located interventions by outcome assessors
12Dance movement therapy for dementia (Protocol)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Attrition bias
Incomplete outcome data: assessments
should be made for each main outcome (or
class of outcomes)
Describe the completeness of outcome data
for each main outcome, including attri-
tion and exclusions from the analysis. State
whether attrition and exclusions were re-
ported, the numbers in each intervention
group (compared with total randomised
participants), reasons for attrition/exclu-
sions where reported, and any re-inclusions
in analyses performedby the review authors
Attrition bias due to amount, nature or
handling of incomplete outcome data
Reporting bias
Selective reporting State how the possibility of selective out-
come reportingwas examined by the review
authors, and what was found
Reporting bias due to selective outcome re-
porting
Other bias
Other sources of bias State any important concerns about bias
not addressed in the other domains in the
tool
If particular questions/entries were pre-
specified in the review’s protocol, responses
should be provided for each question/entry
Bias due to problems not covered elsewhere
in the table
Checklist into which the tool outlined above will be translated
1. Selection bias
a. Random sequence generation
Was the trial reported as randomised? YES/NO/UNCLEAR
Was the method of randomisation appropriate? YES/NO/UNCLEAR
YES: randomisation will be rated as appropriate if every participant had an equal chance to be selected for either intervention and if
the investigator was unable to predict to which treatment the participant would be assigned. Examples of appropriate randomisation
methods include use of: randomnumber table; computer random-number generator; coin tossing; shuffling cards or envelopes; throwing
dice; drawing lots; minimisation.
NO: inappropriate methods include: use of date of birth; sequence generated by a rule e.g. date of admission; patient preference;
clinician’s judgement; availability of the intervention.
UNCLEAR: insufficient information provided on which to base judgement.
b. Allocation concealment
Was allocation concealment adequate? YES/NO/UNCLEAR
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YES: allocation concealment will be rated as adequate when the following methods are used: central allocation (e.g. telephone, web- or
pharmacy-based randomisation); serially-numbered, opaque, sealed envelopes; other descriptions with convincing concealment.
NO: allocation concealment will be rated as inadequate when the following methods are used: open random allocation schedule, i.e. a
list of random numbers; envelopes without safeguards, i.e. unsealed, non-opaque or not sequentially-numbered; alternation or rotation;
date of birth; case record number; any other explicitly unconcealed procedure.
UNCLEAR: authors did not report adequately on method of concealment.
2. Blinding of participants and personnel
Was participant and personnel blinding adequate? YES/NO/UNCLEAR
YES: adequate blinding will involve blinding of participants and personnel to the allocated interventions during the study.
NO: inadequate blinding is implied in studies in which blinding of participants and personnel has not taken place. Please note that for
DMT studies, it is highly likely that it will not be possible to blind participants or those providing the DMT interventions. Therefore,
it is likely that for this domain DMT studies will be assessed as having inadequate blinding and thus being at a high risk of bias.
UNCLEAR: unclear blinding is implied when insufficient information is reported to determine who was blinded, or whether blinding
occurred at all.
3. Blinding of outcome assessment
Was discussion of blinding of outcome assessment adequate? YES/NO/UNCLEAR
YES: adequate blinding achieved when outcome assessors are unaware of the intervention allocated.
NO: inadequate blinding means that outcome assessors are aware of the intervention allocated.
UNCLEAR: a judgement of unclear will be used if a study does not address this point.
4. Incomplete outcome data
Were incomplete outcome data adequately considered? YES/NO/UNCLEAR
YES: incomplete outcome data will have been adequately considered when: there are no missing outcome data; reasons for missing
data are unlikely to be related to the true outcome; missing outcome data are balanced across comparison groups, with similar reasons;
plausible effect size (difference in means or standardised difference in means) among missing outcomes is insufficient to have clinically
relevant impact on observed effect size; missing data are imputed using appropriate methods.
NO: incomplete outcome data will have been inadequately considered when: reasons for missing outcome data are likely to be related
to the true outcome, with either imbalance of numbers or reasons for missing data across groups; plausible effect size among missing
outcomes is sufficient to induce clinically relevant bias in observed effect size; ’as treated’ analysis performed with substantial departure
of the intervention received from that assigned at randomisation; potentially inappropriate application of simple imputation.
UNCLEAR: insufficient reporting of attrition or exclusions to permit judgement, e.g. number randomised not stated or no reasons
provided for missing data; or the study did not address this outcome.
For continuous data, an intention to treat (ITT) analysis will be calculated if not presented by the authors of the study.
5. Selective reporting
Was the reporting bias acceptable? YES/NO/UNCLEAR
YES: reporting bias will be assessed as acceptable if: the study protocol is available and all pre-specified outcomes of interest in the
review have been reported in the pre-specified way; or the protocol is not available but it is clear that the published reports include all
expected outcomes.
NO: reporting bias will be assessed as unacceptable if: not all of the pre-specified primary outcomes are reported; one or more of
these is reported using measurements or analytic methods or subsets of data that were not pre-specified; one or more of the primary
outcomes were not pre-specified (unless clearly justified, e.g. an unexpected adverse effect); one or more outcomes of interest is reported
incompletely and so cannot be entered into meta-analysis; failure to report results for a key outcome that would be expected from such
a study (including adverse outcomes).
UNCLEAR: insufficient information provided to make a judgement.
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6. Other sources of bias
Were other sources of bias eliminated: YES/NO/UNCLEAR
Examples of other risk of bias include: those related to study design; claimed to be fraudulent.
Examples of unclear risk of bias include: insufficient rationale or evidence that an identified problem would introduce bias.
The above criteria will be used to give each article an overall quality rating of A to C, as follows:
A: low risk of bias - all criteria met.
B: moderate risk of bias - one or more of the criteria only partly met.
C: high risk of bias - one or more criteria not met.
Studies will not be excluded on the basis of a low quality score.
D E C L A R A T I O N S O F I N T E R E S T
Both authors are dance movement psychotherapists registered with the Association for Dance Movement Psychotherapy UK and active
researchers in the field with relevant research activities
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Internal sources
• University of Leeds and Queen Margaret University, Other.
The two institutions offered support in the form of learning resources and training on systematic reviews
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